Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.

This study was to investigate the effect of nicotine on insulin sensitivity and explore the underlying mechanisms. Treatment of Sprague-Dawley rats with nicotine (3 mg/kg/day) for 6 weeks reduced 43% body weight gain and 65% blood insulin level, but had no effect on blood glucose level. Both insulin...

Full description

Bibliographic Details
Main Authors: Tian-Ying Xu, Ling-Ling Guo, Pei Wang, Jie Song, Ying-Ying Le, Benoit Viollet, Chao-Yu Miao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23251458/pdf/?tool=EBI
_version_ 1818405412935827456
author Tian-Ying Xu
Ling-Ling Guo
Pei Wang
Jie Song
Ying-Ying Le
Benoit Viollet
Chao-Yu Miao
author_facet Tian-Ying Xu
Ling-Ling Guo
Pei Wang
Jie Song
Ying-Ying Le
Benoit Viollet
Chao-Yu Miao
author_sort Tian-Ying Xu
collection DOAJ
description This study was to investigate the effect of nicotine on insulin sensitivity and explore the underlying mechanisms. Treatment of Sprague-Dawley rats with nicotine (3 mg/kg/day) for 6 weeks reduced 43% body weight gain and 65% blood insulin level, but had no effect on blood glucose level. Both insulin tolerance test and glucose tolerance test demonstrated that nicotine treatment enhanced insulin sensitivity. Pretreatment of rats with hexamethonium (20 mg/kg/day) to antagonize peripheral nicotinic receptors except for α7 nicotinic acetylcholine receptor (α7-nAChR) had no effect on the insulin sensitizing effect of nicotine. However, the insulin sensitizing effect but not the bodyweight reducing effect of nicotine was abrogated in α7-nAChR knockout mice. Further, chronic treatment with PNU-282987 (0.53 mg/kg/day), a selective α7-nAChR agonist, significantly enhanced insulin sensitivity without apparently modifying bodyweight not only in normal mice but also in AMP-activated kinase-α2 knockout mice, an animal model of insulin resistance with no sign of inflammation. Moreover, PNU-282987 treatment enhanced phosphorylation of signal transducer and activator of transcription 3 (STAT3) in skeletal muscle, adipose tissue and liver in normal mice. PNU-282987 treatment also increased glucose uptake by 25% in C2C12 myotubes and this effect was total abrogated by STAT3 inhibitor, S3I-201. All together, these findings demonstrated that nicotine enhanced insulin sensitivity in animals with or without insulin resistance, at least in part via stimulating α7-nAChR-STAT3 pathway independent of inflammation. Our results contribute not only to the understanding of the pharmacological effects of nicotine, but also to the identifying of new therapeutic targets against insulin resistance.
first_indexed 2024-12-14T08:55:39Z
format Article
id doaj.art-62f2afa5fd794069b502659f445fc55e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T08:55:39Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-62f2afa5fd794069b502659f445fc55e2022-12-21T23:08:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5121710.1371/journal.pone.0051217Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.Tian-Ying XuLing-Ling GuoPei WangJie SongYing-Ying LeBenoit ViolletChao-Yu MiaoThis study was to investigate the effect of nicotine on insulin sensitivity and explore the underlying mechanisms. Treatment of Sprague-Dawley rats with nicotine (3 mg/kg/day) for 6 weeks reduced 43% body weight gain and 65% blood insulin level, but had no effect on blood glucose level. Both insulin tolerance test and glucose tolerance test demonstrated that nicotine treatment enhanced insulin sensitivity. Pretreatment of rats with hexamethonium (20 mg/kg/day) to antagonize peripheral nicotinic receptors except for α7 nicotinic acetylcholine receptor (α7-nAChR) had no effect on the insulin sensitizing effect of nicotine. However, the insulin sensitizing effect but not the bodyweight reducing effect of nicotine was abrogated in α7-nAChR knockout mice. Further, chronic treatment with PNU-282987 (0.53 mg/kg/day), a selective α7-nAChR agonist, significantly enhanced insulin sensitivity without apparently modifying bodyweight not only in normal mice but also in AMP-activated kinase-α2 knockout mice, an animal model of insulin resistance with no sign of inflammation. Moreover, PNU-282987 treatment enhanced phosphorylation of signal transducer and activator of transcription 3 (STAT3) in skeletal muscle, adipose tissue and liver in normal mice. PNU-282987 treatment also increased glucose uptake by 25% in C2C12 myotubes and this effect was total abrogated by STAT3 inhibitor, S3I-201. All together, these findings demonstrated that nicotine enhanced insulin sensitivity in animals with or without insulin resistance, at least in part via stimulating α7-nAChR-STAT3 pathway independent of inflammation. Our results contribute not only to the understanding of the pharmacological effects of nicotine, but also to the identifying of new therapeutic targets against insulin resistance.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23251458/pdf/?tool=EBI
spellingShingle Tian-Ying Xu
Ling-Ling Guo
Pei Wang
Jie Song
Ying-Ying Le
Benoit Viollet
Chao-Yu Miao
Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
PLoS ONE
title Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_full Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_fullStr Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_full_unstemmed Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_short Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_sort chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor stat3 pathway
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23251458/pdf/?tool=EBI
work_keys_str_mv AT tianyingxu chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT linglingguo chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT peiwang chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT jiesong chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT yingyingle chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT benoitviollet chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT chaoyumiao chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway